Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism

Background: Evidence suggests that goal anti-Xa levels are achieved in only 33% of critically ill patients receiving standard prophylactic enoxaparin dosing. There has been limited focus on the potential suboptimal anticoagulation effect on medical intensive care unit (MICU) patients receiving thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Aliya, Williams, Caitlin M., Branan, Trisha N., Smith, Susan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2023
Materias:
Idea Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686670/
https://www.ncbi.nlm.nih.gov/pubmed/38035321
http://dx.doi.org/10.24926/iip.v14i1.5174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686670/
https://www.ncbi.nlm.nih.gov/pubmed/38035321
http://dx.doi.org/10.24926/iip.v14i1.5174

Ejemplares similares